EUCTR2011-001682-41-IT进行中（未招募）不适用
Comparison of the efficacy and the safety of different schedules of administration of sub-lingual immunotherapy in patients with ragweed pollinosis: a phase III randomized and controlled clinical study.
AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)0 个研究点目标入组 45 人开始时间: 2011年12月6日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adults aged 18-55 years, known allergy to ragweed pollen, no immunotherapy or in progress prior to enrollement, symptoms of rhino/conjunctivitis with or without asthma.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 45
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Allergic to perennial allergens (moulds, mites and animal when exposed to the animal), patients with chronic diseases (infectious, autoimmune cancer, heart or kidney), pregnancy, chronic drug treatment with steroids and/or immunosuppressive drugs, oral diseases.
研究者
相似试验
已完成
4 期
Comparison of efficacy and safety of Drotaverine Versus Mebeverine in Irritable Bowel SyndromeCTRI/2017/11/010529Walter Bushnell Pvt Ltd200
招募中
不适用
Comparisons of different filling materials in Non carious cervical Lesion .CTRI/2021/08/035494Dr Tanu300
进行中（未招募）
1 期
Comparison of the effectiveness and safety of two different starting dosages of cortisone, compared to each other and to placebo, in early active rheumatoid arthritisEUCTR2012-004074-25-DERuhr-Universität Bochum450
招募中
不适用
Comparison of the the Efficacy and Safety of durable polymer Novolimus-eluting Elixir DESyne X2™ Stent with Bioresorbable Polymer Sirolimus-Eluting Orsiro™ Stent in a Real World” patient populatioKCT0005690Koera University Guro Hospital1,176
已完成
不适用
The comparative study of efficacy and safety in the treatment with mixed-type insulin to combined therapy with long-acting insulin analog and GLP-1 recepter agonist in type 2 DM.Type 2 Diabetes MellitusJPRN-UMIN000016628Hyogo College Of Medicine Division of Diabetes,Endocrinology and Metabolism,Department of Internal Medicine10